TW200740778A - Non-steroidal progesterone receptor modulators - Google Patents

Non-steroidal progesterone receptor modulators

Info

Publication number
TW200740778A
TW200740778A TW095122742A TW95122742A TW200740778A TW 200740778 A TW200740778 A TW 200740778A TW 095122742 A TW095122742 A TW 095122742A TW 95122742 A TW95122742 A TW 95122742A TW 200740778 A TW200740778 A TW 200740778A
Authority
TW
Taiwan
Prior art keywords
receptor modulators
progesterone receptor
therapy
prophylaxis
steroidal progesterone
Prior art date
Application number
TW095122742A
Other languages
English (en)
Inventor
Ulrich Bothe
Peter Droescher
Ulrike Fuhrmann
Alexander Hillisch
Guenter Kaufmann
Carsten Moller
Norbert Schmees
Wolfgang Schwede
Lothar Sobek
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of TW200740778A publication Critical patent/TW200740778A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/021,2-Oxazines; Hydrogenated 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW095122742A 2005-06-24 2006-06-23 Non-steroidal progesterone receptor modulators TW200740778A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005030292A DE102005030292A1 (de) 2005-06-24 2005-06-24 Nichtsteroidale Progesteronrezeptor-Modulatoren

Publications (1)

Publication Number Publication Date
TW200740778A true TW200740778A (en) 2007-11-01

Family

ID=37199176

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095122742A TW200740778A (en) 2005-06-24 2006-06-23 Non-steroidal progesterone receptor modulators

Country Status (22)

Country Link
EP (1) EP1902049A2 (zh)
JP (1) JP2008543910A (zh)
KR (1) KR20080030622A (zh)
CN (1) CN101248066A (zh)
AR (1) AR054519A1 (zh)
AU (1) AU2006261048A1 (zh)
BR (1) BRPI0611903A2 (zh)
CA (1) CA2611897A1 (zh)
CR (1) CR9598A (zh)
DE (1) DE102005030292A1 (zh)
DO (1) DOP2006000148A (zh)
EA (1) EA200702524A1 (zh)
EC (1) ECSP078044A (zh)
GT (1) GT200600271A (zh)
IL (1) IL188021A0 (zh)
MX (1) MX2008000072A (zh)
NO (1) NO20080440L (zh)
PE (1) PE20070125A1 (zh)
TW (1) TW200740778A (zh)
UY (1) UY29624A1 (zh)
WO (1) WO2006136461A2 (zh)
ZA (1) ZA200800690B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) * 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
JP2011519916A (ja) * 2008-07-02 2011-07-14 ファーマコステック カンパニー リミテッド アミド誘導体の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19856475A1 (de) * 1998-11-27 2000-05-31 Schering Ag Nichtsteroidale Entzündungshemmer
EP1344776A1 (en) * 2002-03-11 2003-09-17 Schering Aktiengesellschaft 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
EA200600148A1 (ru) * 2003-07-01 2006-08-25 Шеринг Акциенгезельшафт Гетероциклически замещённые производные пентанола, способ их получения и их применение в качестве ингибиторов воспаления

Also Published As

Publication number Publication date
EP1902049A2 (en) 2008-03-26
CA2611897A1 (en) 2006-12-28
CR9598A (es) 2008-04-09
ECSP078044A (es) 2008-01-23
KR20080030622A (ko) 2008-04-04
UY29624A1 (es) 2007-01-31
BRPI0611903A2 (pt) 2010-10-05
GT200600271A (es) 2007-02-05
ZA200800690B (en) 2009-09-30
CN101248066A (zh) 2008-08-20
PE20070125A1 (es) 2007-02-14
NO20080440L (no) 2008-03-25
DOP2006000148A (es) 2007-07-15
IL188021A0 (en) 2008-03-20
WO2006136461A2 (en) 2006-12-28
WO2006136461A3 (en) 2007-03-15
JP2008543910A (ja) 2008-12-04
AU2006261048A1 (en) 2006-12-28
AR054519A1 (es) 2007-06-27
DE102005030292A1 (de) 2007-01-11
EA200702524A1 (ru) 2008-06-30
MX2008000072A (es) 2008-03-24

Similar Documents

Publication Publication Date Title
WO2011009531A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
WO2011009530A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9 (10)-dien-11-acyloxyalkylenphenyl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
MX2009009581A (es) Indazoles usados para tratar trastornos mediados por el receptor de estrogenos beta.
WO2011009529A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
WO2011098437A3 (de) Progesteronrezeptorantagonisten
UA98138C2 (ru) Производные бензамида как модуляторы фолликулостимулирующего гормона
MX2007002393A (es) Compuestos indolicos sustituidos y su uso como moduladores del receptor de 5-hidroxitriptamina 6 (5-ht6).
WO2007016385A3 (en) Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators
CU24106B1 (es) Compuestos derivados de 6,7-dihidro-5h-benzo[7]anulenos
MX2008000070A (es) Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona.
WO2011009534A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
TW200740778A (en) Non-steroidal progesterone receptor modulators
UY29625A1 (es) Uso de moduladores no esteroides de receptores de progesterona
DE602005019905D1 (de) -modulatoren
HRP20110780T1 (en) Amino arylsulfonamide compounds and their use as 5-ht6 ligands field of invention
WO2008113851A3 (en) Novel c11 modified retrosteroids as progesterone receptor modulator compounds
WO2008077647A3 (de) Alpha-aminoalkohole als nichtsteroidale progesteronrezeptor-modulatoren
UY30815A1 (es) Moduladores no esteroidales del receptor de progesterona
EA201000097A1 (ru) 8-бета-замещенные эстратриены в качестве селективно активных эстрогенов
PT1809602E (pt) Derivados de indole úteis como moduladores do receptor da progesterona
TH85420B (th) การใช้สารปรับโพรเจสเตอโรนรีเซปเตอร์ชนิดนอน-สเตียรอยด์
UA98126C2 (ru) Производные индазолильного эстера и амида для лечения расстройств, опосредованных глюкокортикоидным рецептором